Age-Related Variations: A Retrospective Analysis of 848 Prospectively-Collected Patient Samples to Determine the Benefit of Combinatorial Protein Biomarker Assay for the Detection of Breast Cancer in Women with Dense Breast.

Provista Diagnostics presented this poster at ASCO Breast 2015 demonstrating a non-invasive, blood-based combinatorial proteomic biomarker assay (Videssa® Breast) that is to be used as an adjunct to standard-of-care imaging to detect the presence or absence of breast cancer in patients with dense breasts.

Learn more by downloading the scientific poster

HUPO-2016densebreast.png

Download Poster